<http://schema.org/description>
"(HealthDay)\u2014In acutely ill hospitalized patients, standard-duration rivaroxaban has similar efficacy as enoxaparin in reducing the risk of venous thromboembolism, while extended-duration rivaroxaban has superior efficacy, according to a study published in the Feb. 7 issue of the New England Journal of Medicine."^^<http://www.w3.org/2001/XMLSchema#string>
<http://medicalxpress.com/news/2013-02-rivaroxaban-noninferior-enoxaparin-acutely-ill.html>